- Investing Ideas
- Global Pharmaceuticals & Biotech Spotless Management
Global Pharmaceuticals & Biotech Spotless Management
Results
7
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
7 companies
AstraZeneca
Market Cap: UK£193.8b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£124.92
7D
1.0%
1Y
20.7%
Gilead Sciences
Market Cap: US$165.4b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$130.28
7D
0.2%
1Y
18.3%
Chugai Pharmaceutical
Market Cap: JP¥12.2t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,339.00
7D
3.0%
1Y
3.1%
Orion Oyj
Market Cap: €10.8b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€76.55
7D
12.7%
1Y
9.8%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥59.9b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥131.22
7D
4.6%
1Y
36.6%
Xiamen Amoytop Biotech
Market Cap: CN¥24.6b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥59.36
7D
1.5%
1Y
-21.9%
PharmaResearch
Market Cap: ₩3.5t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩322,500.00
7D
-1.5%
1Y
-44.7%